Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2007

View Archived Issues

Recent patents disclose novel analgesic agents

New treatments for cancer described in recent patents

Snapshots from the European Winter Conference on Brain Research

OxyADF is aversive in subjects with history of opioid abuse

Emergent to use VaxImmune in development of new anthrax vaccines

FDA extends review period for Frova menstrual migraine sNDA

Clearance for Spanish trial of P-144 for scleroderma

Enrollment completed in phase II trials for Amigal

Sanofi-aventis planning European launch of SoloSTAR disposable insulin pen

Trans-sodium crocetinate begins clinical testing

Neuroprotective effects of herbal medicines

Zolpidem improves motor, cognition performance in a patient with akinetic mutism

Sildenafil improves exercise capacity in idiopathic pulmonary fibrosis

Herpes simplex virus shows potential as a diagnostic tool for cancer

Tyrosine kinase inhibitors delay tumor growth in ocular melanoma model

Celecoxib reduces PanIN lesions and papilloma formation in a pancreatic cancer model

Cancer-associated pathways modulated by (S)-HDAC-42

Spectrum updates clinical progress of 2006

New targets for neurodegenerative diseases

Japanese launch for Certican tablets

Lialda now available

EGFR intron 1 status predicts sensitivity to erlotinib in pancreatic cancer cells

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...